SCOPUS 정보 검색 플랫폼

Pharmaceutical Research

Volumn 18, Issue 8, 2001, Pages 1096-1101

Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles

(6) Berton, M a Turelli, P a Trono, D a Stein, C b Allemann E a Gurny, R a

a UNIVERSITY OF GENEVA (Switzerland)

b College of Physicians and Surgeons ^* (United States)

Author keywords

Drug delivery; HIV 1; Nanoparticle; Phosphorothioate oligonucleotide; Reverse transcription

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BETA GALACTOSIDASE; MEDISORB 100DL; NANOPARTICLE; PHOSPHOROTHIOIC ACID; POLYLACTIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENCAPSULATION; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION;

EID: 0034807801 PISSN: 07248741 EISSN: None Source Type: Journal
DOI: 10.1023/A:1010962507273 Document Type: Article

Times cited : (38)

References (30)

1
- 0032724911
- Novel mechanisms for antisense-mediated regulation of gene expression
- (1999) Biochim. Biophys. Acta , vol.1489 , pp. 3-18
- Baker, B.F.¹ Monia, B.P.²

2
- 0032700656
- Molecular mechanisms of action of antisense drugs
- (1999) Biochim. Biophys. Acta , vol.1489 , pp. 31-44
- Crooke, S.T.¹

3
- 0032730429
- Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer
- (1999) J. Clin. Oncol. , vol.17 , pp. 3586-3595
- Nemunaitis, J.¹ Holmlund, J.T.² Kraynak, M.³ Richards, D.⁴ Bruce, J.⁵ Ognoskie, N.⁶ Kwoh, T.J.⁷ Geary, R.⁸ Dorr, A.⁹ Von Hoff, D.¹⁰ Eckhardt, S.G.¹¹

4
- 0034026007
- A phase I trial of c-Raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer
- (2000) Clin. Cancer Res. , vol.6 , pp. 1626-1631
- Cunningham, C.C.¹ Holmlund, J.T.² Schiller, J.H.³ Geary, R.S.⁴ Kwoh, T.J.⁵ Dorr, A.⁶ Nemunaitis, J.⁷

5
- 0034015672
- Phase 1 clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma
- (2000) J. Clin. Oncol. , vol.18 , pp. 1812-1823
- Waters, J.S.¹ Webb, A.² Cunningham, D.³ Clarke, P.A.⁴ Raynaud, F.⁵ Di Stefano, F.⁶ Cotter, F.E.⁷

6
- 0029821897
- Inhibition of human cytomegalovirus immediate-early gene expression by an antisense oligonucleotide complementary to immediate-early RNA
- (1996) Antimicrob. Agents Chemother. , vol.40 , pp. 2004-2011
- Anderson, K.P.¹ Fox, M.C.² Brown-Driver, V.³ Martin, M.J.⁴ Azad, R.F.⁵

7
- 8944263470
- Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication
- (1996) Antimicrob. Agents Chemother. , vol.40 , pp. 1346-1351
- Deminie, C.A.¹ Bechtold, C.M.² Stock, D.³ Alam, M.⁴ Djang, F.⁵ Balch, A.H.⁶ Chou, T.-C.⁷ Prichard, M.⁸ Colonno, R.J.⁹ Lin, P.-F.¹⁰

8
- 0027965903
- HIV-1 reverse transcription: A termination step at the center of the genome
- (1994) J. Mol. Biol. , vol.241 , pp. 651-662
- Charneau, P.¹ Mirambeau, G.² Roux, P.³ Paulous, S.⁴ Buc, H.⁵ Clavel, F.⁶

9
- 0032700356
- Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides
- (1999) Biochim. Biophys. Acta , vol.1489 , pp. 53-68
- Agrawal, S.¹

10
- 0032720361
- Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides
- (1999) Biochim. Biophys. Acta , vol.1489 , pp. 107-116
- Krieg, A.M.¹

11
- 0034601112
- Cellular delivery of antisense oligonucleotides
- (2000) Eur. J. Pharm. Biopharm. , vol.50 , pp. 101-119
- Lebedeva, I.¹ Benimetskaya, L.² Stein, C.A.³ Vilenchik, M.⁴

12
- 0032960982
- Antisense pharmacodynamics: Critical issues in the transport and delivery of antisense oligonucleotides
- (1999) Pharm. Res. , vol.16 , pp. 494-502
- Juliano, R.L.¹ Alahari, S.² Yoo, H.³ Kole, R.⁴ Cho, M.⁵

13
- 0028131976
- Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms
- (1994) Nucleic Acids Res. , vol.22 , pp. 4307-4314
- Zelphati, O.¹ Imbach, J.L.² Signoret, N.³ Zon, G.⁴ Rayner, B.⁵ Leserman, L.⁶

14
- 0031955004
- Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture
- (1998) J. Drug Target. , vol.5 , pp. 149-162
- Bennett, C.F.¹ Mirejovsky, D.² Crooke, R.M.³ Tsai, Y.J.⁴ Felgner, J.⁵ Sridhar, C.N.⁶ Wheeler, C.J.⁷ Feigner, P.L.⁸

15
- 0034650606
- Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides
- (2000) Nucleic Acids Res. , vol.28 , pp. 504-512
- Pichon, C.¹ Roufaï, M.B.² Monsigny, M.³ Midoux, P.⁴

16
- 0028114851
- Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide
- (1994) Nucleic Acids Res. , vol.22 , pp. 4681-4688
- Bongartz, J.-P.¹ Aubertin, A.-M.² Milhaud, P.G.³ Lebleu, B.⁴

17
- 0033404268
- PAMAM dendrimers as delivery agents for antisense oligonucleotides
- (1999) Pharm. Res. , vol.16 , pp. 1799-1804
- Yoo, H.¹ Sazani, P.² Juliano, R.L.³

18
- 0029923715
- Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides
- (1996) Pharm. Res. , vol.13 , pp. 404-410
- Hughes, J.A.¹ Aronsohn, A.I.² Avrutskaya, A.V.³ Juliano, R.L.⁴

19
- 0027517321
- Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans
- (1993) Proc. Natl. Acad. Sci. USA , vol.90 , pp. 11307-11311
- Nabel, G.J.¹ Nabel, E.G.² Yang, Z.Y.³ Fox, B.A.⁴ Plautz, G.E.⁵ Gao, X.⁶ Huang, L.⁷ Shu, S.⁸ Gordon, D.⁹ Chang, A.E.¹⁰

20
- 0029872147
- A serum-resistant cytofectin for cellular delivery of antisense ollgodeoxynucleotides and plasmid DNA
- (1996) Proc. Natl. Acad. Sci. USA , vol.93 , pp. 3176-3181
- Lewis, J.G.¹ Lin, K.Y.² Kothavale, A.³ Flanagan, W.M.⁴ Matteucci, M.D.⁵ Deprince, R.B.⁶ Mook, R.A.⁷ Hendren, R.W.⁸ Wagner, R.W.⁹

21
- 0034595215
- Enhanced antisense efficacy of oligonucleotide adsorbed to monomethylaminoethylmethacrylate methylmethacrylate copolymer nanoparticles
- (2000) Eur. J. Pharm. Biopharm. , vol.49 , pp. 203-210
- Zobel, H.-P.¹ Junghans, M.² Maienschein, V.³ Werner, D.⁴ Gilbert, M.⁵ Zimmermann, H.⁶ Noe, C.⁷ Kreuter, J.⁸ Timmer, A.⁹

22
- 0033005404
- Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localization
- (1999) Eur. J. Pharm. Biopharm. , vol.47 , pp. 119-123
- Berton, M.¹ Benimetskaya, L.² Allémann, E.³ Stein, C.A.⁴ Gurny, R.⁵

23
- 0343415618
- Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex
- (1999) Eur. J. Pharm. Sci. , vol.9 , pp. 163-170
- Berton, M.¹ Allémann, E.² Stein, C.A.³ Gurny, R.⁴

24
- 0031689425
- Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: Characterization of P(LAGA) copolymer microspheres in vitro
- (1998) J. Drug Target. , vol.5 , pp. 291-302
- Lewis, J.K.¹ Irwin, W.J.² Akhtar, S.³

25
- 0032534534
- Sequence-specific RNaseH cleavage of gag mRNA from HIV-1 infected cells by an antisense oligonucleotide in vitro
- (1998) Nucleic Acids Res. , vol.26 , pp. 5670-5675
- Veal, G.J.¹ Agrawal, S.² Byrn, R.A.³

26
- 0030935397
- The multiple inhibitory mechanisms of GEM91, a gag antisense phosphorothioate oligonucleotide, for human immunodeficiency virus type 1
- (1997) Aids Res. Hum. Retrov. , vol.13 , pp. 545-554
- Yamaguchi, K.¹ Papp, B.² Zhang, D.³ Ali, A.N.⁴ Agrawal, S.⁵ Byrn, R.A.⁶

27
- 0030987672
- HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
- (1997) Proc. Natl. Acad. Sci. USA , vol.94 , pp. 9825-9830
- Gallay, T.¹ Hope, T.² Chin, D.³ Trono, D.⁴

28
- 0033013962
- Nef-induced CD4 and major histocompatibility complex calss I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking
- (1999) J. Virol. , vol.73 , pp. 1964-1973
- Mangasarian, A.¹ Piguet, V.² Wang, J.-K.³ Chen, Y.-L.⁴ Trono, D.⁵

29
- 0019507492
- Isolation and properties of moloney murine leukemia virus mutants: Use of a rapid assay for release of virion reverse transcriptase
- (1981) J. Virol. , vol.38 , pp. 239-248
- Goff, S.¹ Traktman, P.² Baltimore, D.³

30
- 0028342861
- Inhibition of human immunodeficiency virus type 1 activity in vitro by oligonucleotides composed entirely of guanosine and thymidine
- (1994) J. AIDS , vol.7 , pp. 560-570
- Ojwang, J.¹ Elbaggari, A.² Marshall, H.B.³ Jarayaman, K.⁴ McGrath, M.S.⁵ Rando, R.F.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.